The use of IFN-ɣ combination with Cpn for microglia activation in this study is primarily due to reports of elevated levels of IFN-ɣ in various neurological disorders and animal models, such as stroke, multiple sclerosis, and AD [66, 88–92]. This evidence concerns the gene CPN1 and multiple sclerosis.